PTC Therapeutics, Inc. (PTCT): Price and Financial Metrics

PTCT POWR Grades

• PTCT scores best on the Value dimension, with a Value rank ahead of 81.68% of US stocks.
• PTCT's strongest trending metric is Growth; it's been moving up over the last 179 days.
• PTCT ranks lowest in Sentiment; there it ranks in the 3rd percentile.

PTCT Stock Summary

• Ptc Therapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 99.88% of US listed stocks.
• Of note is the ratio of Ptc Therapeutics Inc's sales and general administrative expense to its total operating expenses; merely 15.17% of US stocks have a lower such ratio.
• PTCT's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 96.27% of US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to Ptc Therapeutics Inc are PLX, POLY, CCLP, TEN, and CROX.
• Visit PTCT's SEC page to see the company's official filings. To visit the company's web site, go to www.ptcbio.com.

PTCT Valuation Summary

• PTCT's EV/EBIT ratio is -12.8; this is 143.69% lower than that of the median Healthcare stock.
• PTCT's price/earnings ratio has moved down 10.6 over the prior 100 months.
• PTCT's EV/EBIT ratio has moved down 15.2 over the prior 100 months.

Below are key valuation metrics over time for PTCT.

PTCT Growth Metrics

Its 5 year cash and equivalents growth rate is now at 206.95%.
• Its 2 year cash and equivalents growth rate is now at 26.22%.
• Its 3 year net income to common stockholders growth rate is now at -4.12%.

Over the past 52 months, PTCT's revenue has gone up $397,040,000.

The table below shows PTCT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	538.593	-251.332	-523.901
2021-09-30	492.225	-246.858	-454.99
2021-06-30	471.886	-169.009	-391.058
2021-03-31	430.449	-212.674	-454.115
2020-12-31	380.766	-194.071	-438.16
2020-09-30	358.361	-139.911	-441.483

PTCT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PTCT has a Quality Grade of C, ranking ahead of 45.84% of graded US stocks.
• PTCT's asset turnover comes in at 0.235 -- ranking 183rd of 682 Pharmaceutical Products stocks.
• NMTR, ZIOP, and ATXS are the stocks whose asset turnover ratios are most correlated with PTCT.

The table below shows PTCT's key quality metrics over time.